NDC Compounded Drug 71300-6591-1 Bupivacaine Hydrochloride; Lidocaine Hydrochloride
Injection Epidural; Intra-articular; Soft Tissue; Subcutaneous
Compounded Drug Product Information
NDC Crossover Products Matching Bupivacaine Hydrochloride; Lidocaine Hydrochloride
NDC crossover of Lidocaine Hcl And Bupivacaine Hcl with NDC 71300-6591 a human compounded drug with other similar products matching the same substance name (Bupivacaine Hydrochloride; Lidocaine Hydrochloride) and the same administration route (epidural; intra-articular; soft tissue; subcutaneous) or dosage form (injection).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
69194-803-01 | 803 Bupivacaine Hcl 0.375%, Lidocaine Hcl 2% Syringe | Bupivacaine Hcl, Lidocaine Hcl | 10 mL in 1 SYRINGE | Injection | Retrobulbar | Pine Pharmaceuticals Llc |
Frequently Asked Questions
What is the NDC number assigned to 803 Bupivacaine Hcl 0.375%, Lidocaine Hcl 2% Syringe?
803 Bupivacaine Hcl 0.375%, Lidocaine Hcl 2% Syringe was assigned by its manufacturer with NDC product code 71300-6591. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for 803 Bupivacaine Hcl 0.375%, Lidocaine Hcl 2% Syringe?
The NDC package code 71300-6591-1 was assigned to a 1 VIAL in 1 BOX > 5 mL in 1 VIAL of bupivacaine hydrochloride; lidocaine hydrochloride administered epidural; intra-articular; soft tissue; subcutaneous via injection.
Who manufactures this product?
803 Bupivacaine Hcl 0.375%, Lidocaine Hcl 2% Syringe is manufactured by an outsourced facility and labeled by Nubratori, Inc. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 1 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Pine Pharmaceuticals LLC with NDC product codes 69194-803-01.